-
January 15,2019
Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
-
October 19,2019
Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding
-
May 5,2015
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
-
November 27,1995
Prognostic Value of Tumor Infiltrating Lymphocytes in the Vertical Growth Phase of Primary Cutaneous MelanomaJanuary 10,2021
-
January 10,2021
Cellular Therapy for the Treatment of Solid Tumors
-
April 5,2021
Adoptive T cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
-
May 8,2021
Adoptive Cellular Therapy for Solid Tumors
-
March 4, 2020
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
-
July 9, 2021
ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
-
June 21, 2021
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
-
June 2013
Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells
-
April 3, 2015
Adoptive cell transfer as personalized immunotherapy for human cancer
-
June 30, 2021
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
-
Dec 8, 2016
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
-
June 11, 2021
Perspective of tumor-infiltrating lymphocyte treatment in solid tumors
-
July 22, 2013
Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic